598 related articles for article (PubMed ID: 19113797)
1. Antipsychotic-induced hyperprolactinemia.
Bostwick JR; Guthrie SK; Ellingrod VL
Pharmacotherapy; 2009 Jan; 29(1):64-73. PubMed ID: 19113797
[TBL] [Abstract][Full Text] [Related]
2. Clinical implications of antipsychotic-induced hyperprolactinemia in patients with schizophrenia spectrum or bipolar spectrum disorders: recent developments and current perspectives.
Byerly M; Suppes T; Tran QV; Baker RA
J Clin Psychopharmacol; 2007 Dec; 27(6):639-61. PubMed ID: 18004132
[TBL] [Abstract][Full Text] [Related]
3. [Antipsychotic-drug-induced hyperprolactinemia: physiopathology, clinical features and guidance].
Besnard I; Auclair V; Callery G; Gabriel-Bordenave C; Roberge C
Encephale; 2014 Feb; 40(1):86-94. PubMed ID: 23928066
[TBL] [Abstract][Full Text] [Related]
4. Prolactin elevation with antipsychotic medications: mechanisms of action and clinical consequences.
Maguire GA
J Clin Psychiatry; 2002; 63 Suppl 4():56-62. PubMed ID: 11913677
[TBL] [Abstract][Full Text] [Related]
5. Antipsychotic-induced hyperprolactinemia and sexual dysfunction.
Compton MT; Miller AH
Psychopharmacol Bull; 2002; 36(1):143-64. PubMed ID: 12397853
[TBL] [Abstract][Full Text] [Related]
6. Hyperprolactinaemia and antipsychotic therapy in schizophrenia.
Hummer M; Huber J
Curr Med Res Opin; 2004; 20(2):189-97. PubMed ID: 15006013
[TBL] [Abstract][Full Text] [Related]
7. Effects of antipsychotics on sexual and endocrine function in women: implications for clinical practice.
Smith S
J Clin Psychopharmacol; 2003 Jun; 23(3 Suppl 1):S27-32. PubMed ID: 12832947
[TBL] [Abstract][Full Text] [Related]
8. Antipsychotic-induced hyperprolactinaemia, hypogonadism and osteoporosis in the treatment of schizophrenia.
O'Keane V
J Psychopharmacol; 2008 Mar; 22(2 Suppl):70-5. PubMed ID: 18477623
[TBL] [Abstract][Full Text] [Related]
9. Prolactin awareness: an essential consideration for physical health in schizophrenia.
Montejo AL
Eur Neuropsychopharmacol; 2008 May; 18 Suppl 2():S108-14. PubMed ID: 18346598
[TBL] [Abstract][Full Text] [Related]
10. Risperidone-induced symptomatic hyperprolactinaemia in adolescents.
Holzer L; Eap CB
J Clin Psychopharmacol; 2006 Apr; 26(2):167-71. PubMed ID: 16633146
[TBL] [Abstract][Full Text] [Related]
11. Management of psychotropic-induced hyperprolactinemia.
Marken PA; Haykal RF; Fisher JN
Clin Pharm; 1992 Oct; 11(10):851-6. PubMed ID: 1341991
[TBL] [Abstract][Full Text] [Related]
12. The evolution of hyperprolactinaemia as an entity in psychiatric patients.
Kohen D; Wildgust HJ
J Psychopharmacol; 2008 Mar; 22(2 Suppl):6-11. PubMed ID: 18477616
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic-induced hyperprolactinaemia.
Inder WJ; Castle D
Aust N Z J Psychiatry; 2011 Oct; 45(10):830-7. PubMed ID: 21714721
[TBL] [Abstract][Full Text] [Related]
14. Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management.
Haddad PM; Wieck A
Drugs; 2004; 64(20):2291-314. PubMed ID: 15456328
[TBL] [Abstract][Full Text] [Related]
15. Antipsychotic-induced hyperprolactinemia: a cross-sectional survey.
Johnsen E; Kroken RA; Abaza M; Olberg H; Jørgensen HA
J Clin Psychopharmacol; 2008 Dec; 28(6):686-90. PubMed ID: 19011438
[TBL] [Abstract][Full Text] [Related]
16. Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.
Holt RI
J Psychopharmacol; 2008 Mar; 22(2 Suppl):28-37. PubMed ID: 18477618
[TBL] [Abstract][Full Text] [Related]
17. [Antipsychotic-induced symptomatic hyperprolactinemia: clinical consequences and therapeutic strategies].
Pollice R; Di Giovambattista E; Tomassini A; Di Pucchio A; Ussorio D; Roncone R; Casacchia M
Clin Ter; 2007; 158(2):173-9. PubMed ID: 17566521
[TBL] [Abstract][Full Text] [Related]
18. Hyperprolactinemia in a patient with a pituitary adenoma receiving antipsychotic drug therapy.
Carroll RW; Christodoulou P; Baynes KC; Kahn DA
J Psychiatr Pract; 2012 Mar; 18(2):126-9. PubMed ID: 22418404
[TBL] [Abstract][Full Text] [Related]
19. [Antipsychotics and hyperpolactinaemia: pathophysiology, clinical relevance, diagnosis and therapy].
Riecher-Rössler A; Schmid C; Bleuer S; Birkhäuser M
Neuropsychiatr; 2009; 23(2):71-83. PubMed ID: 19573500
[TBL] [Abstract][Full Text] [Related]
20. Increased incidence of autoimmune thyroiditis in patients with antipsychotic-induced hyperprolactinemia.
Poyraz BC; Aksoy C; Balcioğlu I
Eur Neuropsychopharmacol; 2008 Sep; 18(9):667-72. PubMed ID: 18539008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]